UnitedHealthcare, the largest U.S. health insurer, announced it will no longer require prior approval for 1,700 diagnostic codes related to various treatments starting October 1, 2026. This move aims to reduce administrative burdens by 30% by the end of 2026, responding to criticism from patients, doctors, and lawmakers about the complexity and delays caused by prior authorizations. The changes cover a wide range of specialties including cardiology, therapy services, and home health, and apply across UnitedHealthcare's commercial, Medicare Advantage, and ACA plans. This initiative reflects a broader industry trend to simplify healthcare approvals and improve patient care efficiency.
The Schwab U.S. Dividend Equity ETF (SCHD) has gained 29% year-to-date, pushing its share price near a 52-week high and lowering its yield to about 3.1%, close to historic lows. This strong performance means new investors face a lower income yield co...
A $10,000 investment in the Schwab U.S. Dividend Equity ETF (SCHD) made at its 2011 launch now generates a higher annual yield on cost than any new dividend ETF purchase today. SCHD combines quality screening with a focus on dividend growth and yield...
